Emovate
Emovate is a medicine authorised by Swissmedic under authorisation number 43142. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 August 1980 and the authorisation is valid without a time limit. ATC code D07AB01 places the medicine in the group Corticosteroids, dermatological preparations.
| Authorisation number | 43142 |
|---|---|
| Name | Emovate |
| Full name | Emovate, Crème |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D07AB01 |
| First authorisation | 25 August 1980 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Emovate, Crème | B | 25 August 1980 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | g | D07AB01 | 10.05.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Emovate authorised in Switzerland?
Yes. Emovate is authorised by Swissmedic under authorisation number 43142, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Emovate have?
Emovate is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Emovate?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.